Authorities Investigate Misbranded Abhayrab Rabies Vaccine Batch in Delhi
A batch of Abhayrab rabies vaccine vials bearing batch number KE25012 was seized from an unlicensed premises in Delhi and found to be misbranded and not of standard quality by the Central Drugs Laboratory (CDL), Kasauli. Indian Immunologicals Limited (IIL) stated these seized vials were not manufactured by its Human Biologicals Institute division and highlighted 17 differences from genuine samples. Authorities have arrested four individuals and are investigating the source, while regulatory agencies have urged strict vigilance over the batch's distribution to prevent circulation of counterfeit vaccines.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 60/100.
Outlets measured: news18, economictimes, thehindu, deccanherald, economictimes, businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (45–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 5 Sept, 02:24 am. Other outlets followed.